Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
Actor Adrian Grenier defends farmers against criticism from 'woke liberal college kids' and calls for understanding farming realities before judging practices....
Active shooter situation at Brown University, multiple injuries reported. Stay safe....
